Search Results

Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence

Viveve Medical, Inc. today announced topline result from the U.S. Pivotal PURSUIT clinical trial.

January 17, 2023

·

4 min read

Viveve to Participate in Ladenburg Thalmann Healthcare Conference

Viveve Medical, Inc. today announced that Scott Durbin, chief executive officer, will participate in the Ladenburg Thalmann Healthcare Conference, September 29, 2022, in New York City.

September 22, 2022

·

4 min read

Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence

Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s health and the treatment of female stress urinary incontinence (SUI), today announced the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11511110 covering Viveve’s treatment to address SUI in women.

December 1, 2022

·

4 min read

Viveve to Participate in Alliance Global Partners Virtual MedTech Conference

Viveve Medical, Inc. today announced that Scott Durbin, chief executive officer, will participate in the Alliance Global Partners Virtual MedTech Conference, September 21, 2022.

September 15, 2022

·

3 min read

BioMidwest

Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence

Viveve Medical, Inc. announced the Company received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application 16/454,578 covering Viveve’s unique dual-energy treatment to address SUI in women.

October 4, 2022

·

5 min read

Business

Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022

Viveve Medical, Inc. today announced that it will report its third quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, November 10, 2022.

October 27, 2022

·

4 min read

Business

Viveve Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Viveve Medical, Inc., a medical technology company focused on women’s health and the treatment of stress urinary incontinence, reported financial results for the quarter ended June 30, 2022, and will provide a corporate update on its scheduled conference call.

August 11, 2022

·

8 min read

BioMidwest

Viveve to Participate in H.C. Wainwright 24th Annual Global Investment Conference

Viveve Medical, Inc., a medical technology company focused on women’s health and the treatment of stress urinary incontinence, announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright 24th Annual Global Investment Conference, September 12 - 14, 2022.

September 1, 2022

·

4 min read

Viveve Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Pivotal PURSUIT Trial Readout

Viveve Medical, Inc. today announced the launch of a company-wide rebranding initiative that will include content and new graphic elements related to the treatment of SUI in women.

September 27, 2022

·

5 min read

BioMidwest

Viveve to Participate in H.C. Wainwright Global Investment Conference

Viveve Medical, Inc., a medical technology company focused on women’s health, announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright Global Investment Conference, May 23 - 26, 2022.

May 17, 2022

·

3 min read